Home
Kimia Biosciences Ltd PE Ratio

Kimia Biosciences Ltd
NSE: KIMIABIOSCIEN
PE
Key Highlights
- The P/E Ratio of Kimia Biosciences Ltd is 21.2 as of 22 Feb 15:30 PM .
- The P/E Ratio of Kimia Biosciences Ltd changed from 66.7 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
- The Latest Trading Price of Kimia Biosciences Ltd is ₹ 42.25 as of 21 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Kimia Biosciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Kimia Biosciences Ltd
Company Fundamentals for Kimia Biosciences Ltd

Kimia Biosciences Ltd
NSE: KIMIABIOSCIEN
Share Price
Market Price of Kimia Biosciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 42.25 |
20 Feb 2025 | 43.94 |
19 Feb 2025 | 45.9 |
18 Feb 2025 | 46.56 |
17 Feb 2025 | 43 |
14 Feb 2025 | 46.17 |
13 Feb 2025 | 44.99 |
12 Feb 2025 | 43.25 |
11 Feb 2025 | 43.19 |
10 Feb 2025 | 47.26 |
BlinkX Score for Kimia Biosciences Ltd
Asset Value vs Market Value of Kimia Biosciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Kimia Biosciences Ltd | 199.9 | 21.23 |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Kimia Biosciences Ltd | 199.9 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Kimia Biosciences Ltd Explained
₹199.9
Market cap
₹9
Earnings
21.2X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Kimia Biosciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Kimia Biosciences Ltd
Historical Revenue, EBITDA and Net Profit of Kimia Biosciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Kimia Biosciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Kimia Biosciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Kimia Biosciences Ltd
About Kimia Biosciences Ltd
- Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal.
- The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
- The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
- It came out with a public issue in Feb.'95 to part-finance the project.
- Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking.
Kimia Biosciences Ltd News Hub
Kimia Biosciences reports standalone net profit of Rs 1.44 crore in the June 2024 quarter
Net profit of Kimia Biosciences reported to Rs 1.44 crore in the quarter ended June 2024 as against
Read more
21 Aug 24
Kimia Biosciences announces board meeting date
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 14 August 2024. Po
Read more
10 Aug 24
Kimia Biosciences to conduct board meeting
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 5 December 2024 Po
Read more
30 Nov 24
Kimia Biosciences to discuss results
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 14 November 2024 P
Read more
12 Nov 24